by Ariana | Jun 27, 2024 | Article
We are pleased to announce that Belimumab (Benlysta), a prescription drug used to treat adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the Exception Drug Status (EDS) Benefit of the Saskatchewan and Nova Scotia Formularies...
by Ariana | Jun 3, 2024 | Article
Who Can Apply? Resources Available, and Virtual CDCP Information Sessions The Government of Canada has recently launched the Canadian Dental Care Plan (CDCP), designed to ease financial barriers to accessing oral health care for eligible Canadian residents. This plan...
